BioNTech lifts 2021 COVID-19 vaccine output target to 2 billion doses

Article Link: https://torontosun.com/news/world/biontech-lifts-2021-covid-19-vaccine-output-target-to-2-billion-doses

FRANKFURT — Pfizer Inc’s partner BioNTech SE has boosted the 2021 delivery target for their COVID-19 vaccine to 2 billion doses, up from 1.3 billion previously, as they add new production lines and as more doses can be extracted per vial. Special syringes known as low dead space syringes allow for extraction of six vaccine doses from a standard vial, instead of the usual five, avoiding wasting unused liquid left in a syringe.